Accès ouvert
2026
article
OpenAlex
Hend M. Al‐Kaylani, Guadalupe Torres, Carol Holman, Elaine M. Binkley et autres
Purpose Solitary extramedullary plasmacytoma (SEMP) makes up 2-5% of plasma cell dyscrasias and is defined as a plasma cell neoplasm in the absence of systemic multiple myeloma or other dyscrasia. A rare subset of SEMP is plasmacytoma located in the ocular adnexa, …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Juan Vivanco‐Suarez, Nahom Teferi, Alex Belzer, Hend M. Al‐Kaylani et autres
BACKGROUND: Malignant peripheral nerve sheath tumor (MPNST) is an exceedingly rare and aggressive tumor, with limited literature on its management. Herein, we present our series of surgically managed craniospinal MPNSTs, analyze their outcomes, and review the literature. METHODS: We retrospectively reviewed surgically …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Alex Belzer, Nahom Teferi, Hend M. Al‐Kaylani, Juan Vivanco‐Suarez et autres
BACKGROUND: Malignant triton tumors (MTTs) are a rare and aggressive type of malignant peripheral nerve sheath tumor identified histologically by focal rhabdomyoblastic differentiation. OBSERVATIONS: A 37-year-old female with a prior history of Hodgkin lymphoma presented with acute-onset confusion, cognitive deficits, and weakness. …
us
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Juan Vivanco‐Suarez, Nahom Teferi, Alex Belzer, Hend M. Al‐Kaylani et autres
Abstract Background Malignant peripheral nerve sheath tumor (MPNST) is an exceedingly rare and aggressive tumor, with limited literature on its management. Herein, we present our series of surgically managed craniospinal MPNSTs, analyze their outcomes, and review the literature.Methods We retrospectively reviewed surgically …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Jordan L. Schultz, Douglas R. Langbehn, Hend M. Al‐Kaylani, Ellen van der Plas et autres
BACKGROUND: Juvenile-onset Huntington's disease (JOHD) is a rare form of Huntington's disease (HD) characterized by symptom onset before the age of 21 years. Observational data in this cohort is lacking. OBJECTIVES: Quantify measures of disease progression for use in clinical trials of …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Erin E. Reasoner, Ellen van der Plas, Hend M. Al‐Kaylani, Douglas R. Langbehn et autres
INTRODUCTION: We compared neuropsychiatric symptoms between child and adolescent huntingtin gene-mutation carriers and noncarriers. Given previous evidence of atypical striatal development in carriers, we also assessed the relationship between neuropsychiatric traits and striatal development. METHODS: Participants between 6 and 18 years old …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Hend M. Al‐Kaylani, Bradley T. Loeffler, Sarah L. Mott, Melissa Curry et autres
Introduction Younger age at diagnosis is a risk factor for poor health-related quality of life (HRQOL) in long-term breast cancer survivors. However, few studies have specifically addressed HRQOL in young adults with breast cancer (i.e., diagnosed prior to age 40), nor have …
us
(code pays fourni par la source)
2022
peer-review
OpenAlex
Erin E. Reasoner, Ellen van der Plas, Hend M. Al‐Kaylani, Douglas R. Langbehn et autres
Accès ouvert
2021
article
OpenAlex
Hend M. Al‐Kaylani, Erin E. Reasoner, Bradley T. Loeffler, Sarah L. Mott et autres
BACKGROUND: Recent shifts from radiation to chemotherapy-based treatment for acute lymphoblastic leukemia (ALL) have contributed to reduced long-term morbidity. Despite this, ALL survivors remain at increased risk for long-term cognitive impairments. AIM: To identify demographic and treatment factors associated with school performance …
us
(code pays fourni par la source)